Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Keramika Indonesia Assosiasi Tbk. (KIAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Keramika Indonesia Assosiasi Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Keramika Indonesia Assosiasi Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Keramika Indonesia Assosiasi Tbk. diperdagangkan di Rp21 (kapitalisasi pasar 313,51 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Keramika Indonesia Assosiasi Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

KIASOBAT
Kapitalisasi Pasar
313,51 M166,01 M
Volume
324 rb
Lot
3,24 rb
Perputaran
77,68 jt
Harga Rata-rata
239,75
Nilai Transaksi
77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KIAS
Lihat detail
OBAT
Lihat detail

Tentang Keramika Indonesia Assosiasi Tbk.

KIA Group is one of the most diversified ceramic manufacturers in Indonesia, manufacturing Floor tiles (KSM), wall ties (KIA) and roof tiles (KKM). From their modest origins, a small ceramic tableware producer in the 1950s, KIA Group has to grown up to become Indonesias leading ceramic building material manufacturer. KIA Group received official recognition of its quality management system standard from SGS certification ISO 9002 no. Q4724 in 1995. In addition, KIA Group is in compliance with the World Bank Environmental and Social Policy Standard.

Selengkapnya di halaman KIAS

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT